Viewing Study NCT01316458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-01-10 @ 4:39 PM
Study NCT ID: NCT01316458
Status: COMPLETED
Last Update Posted: 2017-06-01
First Post: 2011-03-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostatic Neoplasm View
None Genital Neoplasms, Male View
None Neoplasms, Abdominal View
None Urogenital Neoplasms View
None Genital Diseases, Male View
None Prostatic Diseases View
None Antineoplastic Agents View
None Imatinib View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate cancer, View
None radical prostatectomy, View
None PSA rise View